Sep 14, 2018 8:00am EDT Pieris Pharmaceuticals to Present Preclinical Data for Inhaled IL-4Rα Antagonist AZD1402/PRS-060 at the ERS International Congress 2018
Sep 10, 2018 8:00am EDT Pieris Pharmaceuticals Appoints Peter Kiener, D.Phil. to its Board of Directors
Sep 04, 2018 8:00am EDT Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Combination Trial for PRS-343 Plus Anti-PD-L1 Immunotherapy
Aug 30, 2018 8:00am EDT Pieris Pharmaceuticals to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
Aug 09, 2018 7:00am EDT Pieris Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update
Aug 08, 2018 8:00am EDT Pieris Pharmaceuticals to Present at the 2018 Wedbush PacGrow Healthcare Conference
Aug 01, 2018 8:00am EDT Pieris Pharmaceuticals to Host Second Quarter 2018 Investor Call and Corporate Update on August 9, 2018
May 31, 2018 8:00am EDT Pieris Pharmaceuticals to Present at Jefferies 2018 Global Healthcare Conference
May 10, 2018 7:00am EDT Pieris Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update
May 03, 2018 8:00am EDT Pieris Pharmaceuticals to Present at 43rd Annual Deutsche Bank Health Care Conference
